Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy

被引:1
|
作者
Pan, Wei [1 ]
Zhang, Qiankun [2 ]
Gong, Xiaohua [1 ]
Wu, Wenjun [1 ]
Zhou, Qi [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Wenzhou 325015, Peoples R China
[2] Zhejiang Univ, Wenzhou Med Univ, Lishui Cent Hosp, Dept Nephrol,Affiliated Hosp 5,Lishui Hosp, Lishui 323000, Peoples R China
关键词
TNF; Extracellular matrix; Dendritic cell; Diabetic nephropathy; Glycosaminoglycan degradation; KIDNEY-DISEASE; HIGH GLUCOSE; EXPRESSION; MODEL; CELL; TNF;
D O I
10.1186/s40001-024-02120-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients remains unclear. The present study aims to establish a connection between extracellular proteins and DN with the goal of identifying potential biomarkers for this condition. Methods Differentially expressed genes (DEGs) between DN kidney tissue and healthy kidney tissue were analyzed using the public data GSE166239. Two gene lists encoding extracellular proteins were then utilized to identify extracellular protein-differentially expressed genes (EP-DEGs). Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, were performed on these EP-DEGs. A protein-protein interaction (PPI) network was established to identify key EP-DEGs. Furthermore, the diagnostic ability, immune cell infiltration, and clinical relevance of these EP-DEGs were investigated. Immunohistochemistry (IHC) staining of paraffin-embedded renal tissues was performed to validate the accuracy of the bioinformatic results. Results A total of 1204 DEGs were identified, from which 162 EP-DEGs were further characterized by overlapping with extracellular protein gene lists. From the PPI network analysis, five EP-DEGs (e.g., TNF, COL1A1, FN1, MMP9, and TGFB1) were identified as candidate biomarkers. TNF, COL1A1, and MMP9 had a high diagnostic accuracy for DN. Assessment of immune cell infiltration revealed that the expression of TNF was positively associated with resting dendritic cells (DCs) (r = 0.85, P < 0.001) and M1 macrophages (r = 0.62, P < 0.05), whereas negatively associated with regulatory T cells (r = - 0.62, P < 0.05). Nephroseq v5 analysis demonstrated a negative correlation between the estimated glomerular filtration rate (eGFR) and TNF expression (r = - 0.730, P = 0.025). Gene set enrichment analysis (GSEA) revealed significant enrichment of glycosaminoglycan (GAG) degradation in the high-TNF subgroup. IHC staining of renal tissues confirmed significantly elevated TNF-a expression and decreased hyaluronic acid (HA) levels in the DN group compared to controls (both P < 0.05), with a negative correlation observed between TNF-a and HA (r = - 0.691, P = 0.026). Conclusion Our findings suggest that TNF may play a pivotal role in the progress of DN by driving ECM accumulation, and this process might involve GAG degradation pathway activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
    Kato, Mitsuo
    Natarajan, Rama
    YEAR IN DIABETES AND OBESITY, 2015, 1353 : 72 - 88
  • [22] Identification of ferroptosis-related genes as potential diagnostic biomarkers for diabetic nephropathy based on bioinformatics
    Guo, Binbin
    Li, Minhui
    Wu, Peipei
    Chen, Yan
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [23] Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy
    Zhu, Chao
    Liang, Qiong-lin
    Hu, Ping
    Wang, Yi-ming
    Luo, Guo-an
    TALANTA, 2011, 85 (04) : 1711 - 1720
  • [24] Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis
    Nie, Han
    Yang, Huan
    Cheng, Lidan
    Yu, Jianxin
    JOURNAL OF DIABETES RESEARCH, 2024, 2024
  • [25] The role of non-coding RNAs in diabetic nephropathy: Potential applications as biomarkers for disease development and progression
    Alvarez, M. Lucrecia
    DiStefano, Johanna K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 99 (01) : 1 - 11
  • [26] Biomarkers: New Advances in Diabetic Nephropathy
    Chen, Yujia
    Liu, Xinan
    Shengbu, Meniga
    Shi, Qian
    Jiaqiu, Suolang
    Lai, Xianrong
    NATURAL PRODUCT COMMUNICATIONS, 2025, 20 (02)
  • [27] Identification and validation of six proteins as marker for endemic nephropathy
    Pesic, Ivana
    Stefanovic, Vladisav
    Mueller, Gerhard A.
    Mueller, Claudia A.
    Cukuranovic, Rade
    Jahn, Olaf
    Bojanic, Vladmila
    Koziolek, Michael
    Dihazi, Hassan
    JOURNAL OF PROTEOMICS, 2011, 74 (10) : 1994 - 2007
  • [28] Identification of Ferroptosis-related Genes for Diabetic Nephropathy by Bioinformatics and Experimental Validation
    Song, Siyuan
    Yu, Jiangyi
    CURRENT PHARMACEUTICAL DESIGN, 2025,
  • [29] Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy
    Xu, Danping
    Jiang, Chonghao
    Xiao, Yonggui
    Ding, Hanlu
    FRONTIERS IN GENETICS, 2023, 14
  • [30] Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy
    Tang, Li Qin
    Wang, Feng Ling
    Zhu, Ling Na
    Lv, Fei
    Liu, Sheng
    Zhang, Shan Tang
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (06) : 3913 - 3923